Pienomial develops Knolens, an AI-powered pharmaceutical intelligence platform that integrates scientific, regulatory, and clinical data to provide real-time, traceable insights supporting Clinical, HEOR, Market Access, Regulatory, and Strategy teams in drug development and market entry across over 100 therapeutic indications. The platform accelerates decision-making by automating literature reviews, modeling clinical trials, tracking regulatory pathways, and simulating market scenarios, enabling faster submissions, optimized trial designs, and competitive intelligence with over 95% AI accuracy.